Literature DB >> 11387131

Positron Emission Tomography in Grading Soft Tissue Sarcomas.

Janet F. Eary1, Ernest U. Conrad.   

Abstract

Soft tissue sarcomas present with varied radiological appearances. Positron imaging with [F-18] fluorodeoxyglucose (FDG PET) has recently made promising contributions to management of patients by providing a noninvasive means for evaluating tumor metabolism and providing important biological information about soft tissue malignant tumors. PET imaging not only gives quantitative data on metabolic rates of tumors but can also readily provide semiquantitative data of uptake of tumors by measuring uptake ratios. These values have been helpful for noninvasively grading tumors. This value is called the tumor standard uptake value (SUV). The tumor grades (low, intermediate, high) mean SUV values show a high level of significance in discrimination among tumor grade groups.

Entities:  

Year:  1999        PMID: 11387131     DOI: 10.1055/s-2008-1080057

Source DB:  PubMed          Journal:  Semin Musculoskelet Radiol        ISSN: 1089-7860            Impact factor:   1.777


  4 in total

1.  The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas.

Authors:  Sung Gwe Ahn; Sung Hoon Kim; Tae Joo Jeon; Ho Jin Cho; Sae Byeol Choi; Mi Jin Yun; Jong Doo Lee; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2011-09-09       Impact factor: 3.452

2.  FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma.

Authors:  Cheryl B Vernon; Janet F Eary; Brian P Rubin; Ernest U Conrad; Scott Schuetze
Journal:  Skeletal Radiol       Date:  2003-02-06       Impact factor: 2.199

3.  Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.

Authors:  Janet F Eary; Finbarr O'Sullivan; Janet O'Sullivan; Ernest U Conrad
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

4.  Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics.

Authors:  Stephanie E W Punt; Janet F Eary; Janet O'Sullivan; Ernest U Conrad
Journal:  Nucl Med Commun       Date:  2009-07       Impact factor: 1.690

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.